Hello,
Due to a sharp increase in subscription costs, I need to reevaluate sources for pharmaceutical pipeline and company transactions. Has anyone seen a good article recently comparing resources?
Any other comments, especially any suggestions of good "bang for the buck" , searchability, and report generation would be very welcome.
------------------------------
Kimberley Emmons
Washington Research Fdn
1-206-336-5600
------------------------------